Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis branded products company in the U.S., today released its unaudited financial and operational results for the three and nine months ended September 30, 2019, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and with the Canadian Securities Exchange (the “CSE”).
Q3 Financial Highlights (amounts are approximate and are stated in U.S. Dollars, unless stated otherwise):
Revenues climbed to $3.5 million in Q3 2019, representing a 38%
year-over-year growth compared to Q3 2018 net revenues of $2.6 million.
Gross Revenues increased to $3.9 million, representing a 50%
year-over-year growth compared to Q3 2018 of $2.6 million. Discounts
& Promotional expenses in Q3 2019 of $0.4 million were driven
primarily by carryover of one-time costs from the launch of the PLUS
Mints in Q2 2019.
- Gross profit was $0.4 million in Q3
2019, compared with $0.4 million in Q3 2018. Gross profit margin of 13%
in Q3 2019 was down quarter-over-quarter from 20% in Q2 2019 due to
start-up costs for the PLUS Hemp CBD launch and Nevada adult-use market
launch, as well as the carryover promotional costs discussed above.
on operating expenses was $9.9 million in Q3 2019, up from $2.1 million
in Q3 2018 due to one-time start-up costs associated with the
rebranding of the PLUS cannabis line, the nationwide launch of the PLUS
hemp CBD line, Nevada adult-use market launch and other investments in
building talent, market share, infrastructure and financial capacity to
support its future growth. Of these expenses, $3.5 million were one-time
- The Company reported $22.3 million in cash and cash
equivalents at September 30, 2019. PLUS experienced planned cash out
flows in Q3 which were significantly greater than ongoing structural
spend due to the launch of Hemp CBD and Nevada adult-use operations, a
significant portion of which were prepaid expenses with value expected
to be realized over the next 4 quarters.
- Net working
capital was $29.1 million in Q3 2019 compared to $22.4 million in Q4
2018. Current liabilities as of September 30, 2019 were $3.0 million as
compared to $2.2 million at December 31, 2018.
- Shareholder equity reached $17.5 million at September 30, 2019, compared to $25.7 million at December 31, 2018 due to the $20.2 million net loss for the first nine months of 2019, offset partially by proceeds from warrant exercises and the impact of share-based compensation.
Q3 Operational Update:
rebrand of PLUS cannabis infused edibles line following proprietary
market structure research conducted by Henry J Rak Associates, with
design work provided by Partners & Spade, known for their work with
Warby Parker and Peloton.
- Launched first California-wide marketing campaign with billboards and other out-of-home media across major cities.
- Launched Hemp CBD product line nationwide through direct-to-consumer e-commerce platform at plusproducts.com.
- Debuted a new product line, rolling out a second line of cannabis infused-gummies in California.
Post Period End:
into the Nevada adult-use market following a successful
commercialization of the partnership with Nevada licensed operator
Taproot Holdings Inc. four months following a definitive agreement.
- Appointed e-commerce senior executive, Jill Braff, to the Company’s Board of Directors, and Dr. Ari Mackler as the Company’s Chief Scientific Officer.
“In the third quarter of 2019 we reported another period of revenue growth and invested heavily in building a strong platform for brand expansion moving forward,” said Jake Heimark, co-founder & Chief Executive Officer of the Company. “We successfully launched our 100% Hemp CBD line, now available for purchase in 43 states, and laid the foundation for our Nevada market entry, which materialized just days following the quarter end.
“While our topline growth was less robust than we had hoped entering the quarter, our team has done a great job battling tough market conditions in California, maintaining a significant 21% share of the gummies market1.
“Despite the uncertain conditions faced by management teams in the industry, both on the ground and in the capital markets, we have continued to invest in growth. Over the last few months we have launched an advertising campaign in California, launched a new product line, and entered two strategically important markets. Less than a month after entering the Nevada market, PLUS Uplift Sour Watermelon is a top 10 selling edible product2. Despite significant spend this quarter, we maintain a strong capital position with over $22 million USD on hand. We expect this represents enough cash to pursue our strategic plan for a full year without external funding.
“PLUS remains confident in our strategic positioning as a hyper-focused CPG brand built within the California edibles market. Today, California represents 38% of the global adult-use market and is expected to maintain a 27% share of that market through 20243. We have seen ingestibles continue to show the most defensible price premiums on shelves4 and they are growing as a percentage of the market5 as consumers learn that inhalable products are not the safest way to consume cannabis. For these reasons, it continues to be our belief that the branded products winner in cannabis will emerge from the California edibles markets. In California today, PLUS has the best-selling cannabis product across all categories and maintains a position as a leader within the state’s edibles market6.
“We are excited about our prospects for growth over the next year, with a multi-state expansion model that is already proving itself in the market, our direct-to-consumer and wholesale hemp CBD businesses gaining traction, and the expected growth of our home market here in California7.”
For further information, please refer to summary of unaudited financial information at the end of this press release as well as the Company’s unaudited financial statements along with the related MD&A (Management Discussion and Analysis) filed under the Company’s profile at www.sedar.com and with the CSE.
1 In Q3 2019 according to Headset Insights.
2 As of November, 29th 2019 according to Headset Insights best-selling edibles list.
3 The State of Legal Cannabis Markets 7th Edition – Arcview | BDS Analytics.
4 BDS Analytics GreenEdge Platform
5 BDS Analytics GreenEdge Platform
6 PLUS has the #1 best-selling cannabis product in California over the last twelve months according to Headset Insights.
7 The State of Legal Cannabis Markets 7th Edition – Arcview | BDS Analytics.
Conference Call Details
On Monday, December 2, 2019 at 8:30am Eastern Time / 5:30am Pacific Time, the Company will host a conference call and webcast to discuss the financial results and its recent corporate highlights.
Participant Dial-In Numbers:
Toll / International: 1-201-689-8560
*Participants should request the Plus Products Earnings Call or provide confirmation code 13696648
The call will be webcast on the Plus Products Investor page of the Company website at https://www.plusproductsinc.com. Please visit the website at least 15 minutes prior to the call to register, download, and install any necessary audio software. Following the conclusion of the call, there will be an archived audio webcast of the conference call available for replay on the Plus Products website or at this link.
Jake Heimark, Co-founder and Chief Executive Officer and Jon Paul, Chief Financial Officer will be conducting a question and answer session following the prepared remarks.
California THC: PLUS cannabis-infused edibles are available in over 360 licensed retailers across the state of California.
Nevada THC: PLUS cannabis-infused gummies are currently available in 30 Nevada dispensaries, including all three MedMen locations and Planet 13. They are expected to be rolled out to more dispensaries across Nevada in the coming weeks.
National Hemp CBD: PLUS recently launched a line of 100% Hemp CBD-infused gummies. They are available for purchase in 43 states across the country at plusproducts.com.